Freeline Therapeutics Holdings plc Income Statement | Understand Stock

Login

Understand Stock

Sign in or create a free account to unlock 10 years of data, build your watchlist, create alerts and more.

Sign in

$6.48 +$0.00 (0.0%)

Deep Research with AI Research

Overview

Overview Financials SEC Filings Executives News

Specialized Tools

Valuations P Insider Transactions P Congressional Trades P

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Income Statement

Concept	2022	2021	2020	2019
Revenue	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A
Cost Of Revenue	N/A	N/A	N/A	$25.51M 12.38% YoY
Gross Profit	N/A	N/A	N/A	-$25.51M 12.38% YoY
Selling, General & Admin	$42.21M -5.28% YoY	$44.57M 69.46% YoY	$26.30M 58.43% YoY	$16.60M 144.48% YoY
Research & Development	$66.20M -30.63% YoY	$95.43M 25.32% YoY	$76.15M 253.53% YoY	$21.54M 87.47% YoY
Depreciation & Amortization	$1.741M -27.15% YoY	$2.390M 25.13% YoY	$1.910M 24.03% YoY	$1.540M 58.76% YoY
Operating Expenses	$98.45M -29.68% YoY	$140.0M 36.65% YoY	$102.5M 168.69% YoY	$38.13M 108.59% YoY
Operating Profit	-$98.45M -30.86% YoY	-$142.4M 38.98% YoY	-$102.4M 60.98% YoY	-$63.64M 55.3% YoY
Interest Expense	$904.0K 123.76% YoY	$404.0K 44.29% YoY	$280.0K -315.38% YoY	-$130.0K -86.32% YoY
Other Income/Expense, Net	$9.843M 411.06% YoY	$1.926M -67.79% YoY	$5.980M -40.2% YoY	$10.00M 15.21% YoY
Pretax Income	-$88.60M -36.73% YoY	-$140.0M 45.6% YoY	-$96.19M 78.89% YoY	-$53.77M 61.67% YoY
Income Tax	$368.0K 7.6% YoY	$342.0K 163.08% YoY	$130.0K -7.14% YoY	$140.0K 366.67% YoY
Net Earnings	-$88.97M -36.63% YoY	-$140.4M 45.75% YoY	-$96.32M 78.67% YoY	-$53.91M 61.99% YoY
Basic Earnings Per Share	-$1.50 -61.83% YoY	-$3.93 -42.29% YoY	-$6.81 N/A	N/A
Diluted Earnings Per Share	-$1.50 -100.0% YoY	-$3.932M 46.35% YoY	-$2.687M 73.14% YoY	-$1.552M 61.99% YoY
COMMON SHARES	N/A	N/A	N/A	N/A
Basic Shares Outstanding	59.27M 66.01% YoY	35.70M 152.28% YoY	14.15M N/A	N/A
Diluted Shares Outstanding	59.27M 66.01% YoY	35.70M 152.28% YoY	14.15M N/A	N/A

Concept	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4
Revenue	$5.000K N/A	$617.0K N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A
Cost Of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Admin	$6.968M -44.56% YoY	$10.12M -26.32% YoY	$8.662M -27.62% YoY	$6.746M -8.19% YoY	$12.57M -0.29% YoY	$13.73M -5.57% YoY	$11.97M 18.74% YoY	$7.348M N/A
Research & Development	$5.240M -52.1% YoY	$8.241M -37.4% YoY	$10.28M -36.54% YoY	$11.54M -53.08% YoY	$10.94M -51.8% YoY	$13.16M -45.76% YoY	$16.20M -32.1% YoY	$24.60M N/A
Depreciation & Amortization	$389.0K -4.19% YoY	$433.0K -9.6% YoY	$320.0K -40.85% YoY	$315.0K -48.45% YoY	$406.0K -30.95% YoY	$479.0K -22.49% YoY	$541.0K -5.58% YoY	$611.0K N/A
Operating Expenses	$12.21M -48.07% YoY	$18.36M -31.74% YoY	$18.95M -32.75% YoY	$18.29M -42.76% YoY	$23.51M -33.41% YoY	$26.89M -30.7% YoY	$28.17M -17.0% YoY	$31.95M N/A
Operating Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$98.00K -66.89% YoY	$34.00K -86.45% YoY	$206.0K 145.24% YoY	$273.0K 405.56% YoY	$296.0K 248.24% YoY	$251.0K 100.8% YoY	$84.00K -40.0% YoY	$54.00K N/A
Other Income/Expense, Net	$121.0K -98.55% YoY	-$388.0K -116.74% YoY	$925.0K -32.78% YoY	-$3.123M 2791.67% YoY	$8.368M 92.32% YoY	$2.318M -296.11% YoY	$1.376M -221.23% YoY	-$108.0K N/A
Pretax Income	-$12.05M -18.84% YoY	-$16.00M -34.2% YoY	$1.328M -104.97% YoY	-$22.73M -33.91% YoY	-$14.84M -51.91% YoY	-$24.32M -38.98% YoY	-$26.71M -23.54% YoY	-$34.39M N/A
Income Tax	$41.00K -18.0% YoY	$6.000K -75.0% YoY	$162.0K 636.36% YoY	$272.0K -13.1% YoY	$50.00K 284.62% YoY	$24.00K 242.86% YoY	$22.00K 144.44% YoY	$313.0K N/A
Net Earnings	-$12.09M -18.83% YoY	-$16.01M -34.24% YoY	$1.166M -104.36% YoY	-$23.00M -33.72% YoY	-$14.89M -51.77% YoY	-$24.35M -38.93% YoY	-$26.73M -23.5% YoY	-$34.70M N/A
Basic Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Earnings Per Share	-$0.18 -100.0% YoY	-$3.69 -100.0% YoY	$0.27 -100.0% YoY	-$0.35 -100.0% YoY	-$229.2K -73.48% YoY	-$377.3K -66.23% YoY	-$626.9K -36.04% YoY	-$970.4K N/A
COMMON SHARES	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	N/A	N/A	N/A	65.11M N/A	N/A	N/A	N/A	N/A
Diluted Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Loading...